Diabetes in your DNA? Scientists zero in on the genetic signature of risk
Many different mutations linked to Type 2 diabetes all occur in key stretches of active DNA within pancreatic islet cells, interfering with the activity of a master regulator.
Why do some people get Type 2 diabetes, while others who live the same lifestyle never do?
For decades, scientists have tried to solve this mystery – and have found more than 80 tiny DNA differences that seem to raise the risk of the disease in some people, or protect others from the damagingly high levels of blood sugar that are its hallmark.
Disruption of regulatory grammar plays a significant role in the genetic risk of Type 2 diabetes.
But no single “Type 2 diabetes signature” has emerged from this search.
Now, a team of scientists has reported a discovery that might explain how multiple genetic flaws can lead to the same disease.
They’ve identified something that some of those diabetes-linked genetic defects have in common: they seem to change the way certain cells in the pancreas “read” their genes.
The discovery could eventually help lead to more personalized treatments for diabetes. But for now, it’s the first demonstration that many Type 2 diabetes-linked DNA changes have to do with the same DNA-reading molecule. Called Regulatory Factor X, or RFX, it’s a master regulator for a number of genes.
The team reporting the findings in a new paper in the Proceedings of the National Academy of Sciences comes from The Jackson Laboratory for Genomic Medicine, the University of Michigan (U-M), National Institutes of Health, University of North Carolina, and the University of Southern Cal Continue reading